← All diseases Rare and hereditary disorders

Hereditary ATTR amyloidosis

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchOnly the strongest evidence (80)Meta-analysis (11)Treatment guideline (1)Phase 3 study (30)Randomized trial (23)Systematic review (15)Clinical trial (344)Overview article (148)Early study (phase 1 or 2) (7)Case report (135)Laboratory or animal study (8)Commentary or editorial (72) Studies currently recruiting participants only (37)

Filter

Publications and studies (1288)

• Commentary or editorialiAn expert's opinion or commentary, not new research. Cardiac Resynchronization Therapy for Transthyretin Cardiac Amyloidosis. (2020/07/21) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Early Progression of Aortic Stenosis Associated With Iatrogenic Variant Transthyretin Amyloidosis After Domino Liver Transplantation. (2020/07/15) ♡
• Hereditary ATTR Amyloidosis in Austria: Prevalence and Epidemiological Hot Spots. (2020/07/14) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. V122I Transthyretin Cardiomyopathy: An Opportunity to Build Trust and Resolve Disparities. (2020/07/07) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Overview of treatments used in transthyretin-related hereditary amyloidosis: a systematic review. (2020/07/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. How to Image Cardiac Amyloidosis: A Practical Approach. (2020/06/01) ♡
• Societal costs and burden of hereditary transthyretin amyloidosis polyneuropathy. (2020/06/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis. (2020/06/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Rationale for a Singapore Transthyretin Amyloidosis Registry. (2020/06/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Tafamidis: A First-in-Class Transthyretin Stabilizer for Transthyretin Amyloid Cardiomyopathy. (2020/05/01) ♡
• Novel insights into rare cardiomyopathies: arrhythmogenic cardiomyopathy, non-compaction, and transthyretin amyloidosis. (2020/04/07) ♡
• Cellular secretion and cytotoxicity of transthyretin mutant proteins underlie late-onset amyloidosis and neurodegeneration. (2020/04/01) ♡
• Syncope as a Phenotypic Expression of Hereditary Transthyretin Amyloidosis Val142Ile (Val122Ile). (2020/04/01) ♡
• Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Inotersen preserves or improves quality of life in hereditary transthyretin amyloidosis. (2020/04/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis. (2020/04/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Amyloid Cardiomyopathy. (2020/04/01) ♡
• Cardiac manifestations and prognostic implications of hereditary transthyretin amyloidosis associated with transthyretin Ala97Ser. (2020/03/01) ♡
• APOE polymorphism in ATTR amyloidosis patients treated with lipid nanoparticle siRNA. (2020/03/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Inotersen therapy of transthyretin amyloid cardiomyopathy. (2020/03/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Coexistence of wild type and hereditary ATTR amyloidosis in one family. (2020/03/01) ♡
• Biomarkers and Prediction of Prognosis in Transthyretin-Related Cardiac Amyloidosis: Direct Comparison of Two Staging Systems. (2020/03/01) ♡
• Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis. (2020/03/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Severe hypocupremia and familial amyloid polyneuropathy]. (2020/02/17) ♡
• Diagnosis of genetic amyloidosis through the analysis of transthyretin gene mutation using high-resolution melting. (2020/02/15) ♡
• Estimating cancer risk from (99m)Tc pyrophosphate imaging for transthyretin cardiac amyloidosis. (2020/02/01) ♡
• Pattern of myocardial (99m)Tc-HMDP uptake and impact on myocardial function in patients with transthyretin cardiac amyloidosis. (2020/02/01) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Cardiac amyloidosis imaging with amyloid positron emission tomography: A systematic review and meta-analysis. (2020/02/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Transthyretin familial amyloid polyneuropathy due to Ile107Val mutation mimicking atypical chronic inflammatory demyelinating polyneuropathy: case report. (2020/02/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Beneficial Effect of Pimobendan for Severe Heart Failure Due to Transthyretin Cardiac Amyloidosis. (2020/02/01) ♡
• Nonclinical Safety Profile of Revusiran, a 1st-Generation GalNAc-siRNA Conjugate for Treatment of Hereditary Transthyretin-Mediated Amyloidosis. (2020/02/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The quintessential form of diastolic heart failure in older adults: Wild type transthyretin cardiac amyloidosis. (2020/02/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Regression of Bone-Tracer Uptake in Cardiac Transthyretin Amyloidosis. (2020/02/01) ♡
• Transthyretin amyloidosis: Putting myopathy on the map. (2020/01/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Expanding the spectrum of transthyretin amyloidosis. (2020/01/01) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. First-in-Human Study of AG10, a Novel, Oral, Specific, Selective, and Potent Transthyretin Stabilizer for the Treatment of Transthyretin Amyloidosis: A Phase 1 Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Healthy Adult Volunteers. (2020/01/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Familial Oculo-Leptomeningeal Transthyretin Amyloidosis Caused by Leu55Arg Mutation. (2020/01/01) ♡
• [Cardiac Transthyretin Amyloidosis]. (2020/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Development and Clinical Applications of Antisense Oligonucleotide Gapmers. (2020/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Inotersen for the Treatment of Hereditary Transthyretin Amyloidosis. (2020/01/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Doxycycline and TUDCA in Patients With Transthyretin Amyloid Cardiomyopathy (2020-12-04) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Cardiac Amyloidosis : Diagnostic Using Red Flag Signals (2020-11-17) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Patient-Reported Outcome Measures in Wild-Type and Variant Cardiac Transthyretin Amyloidosis (2020-09-24) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Assessment of Cardiac Fixation During PET Using a New Drug Within Amyloid Cardiac Injuries. (2020-08-26) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Noninvasive Assessment of Myocardial Stiffness by 2D-SWE Ultrasound Technique (Bidimensional Shear Wave Elastography) in Patients With Transthyretin Amyloidosis (2020-07-02) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Morpho-functional Cardiac Modifications in Treated Mutated Transthyretin Cardiac Amyloidosis (2020-05-13) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. A Statement on the Appropriate Administration of Tafamidis in Patients With Transthyretin Cardiac Amyloidosis. (2019/12/25) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Recent advances in the treatment of chronic heart failure. (2019/12/20) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Association of the V122I Hereditary Transthyretin Amyloidosis Genetic Variant With Heart Failure Among Individuals of African or Hispanic/Latino Ancestry. (2019/12/10) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Gastrointestinal Manifestations in Hereditary Transthyretin Amyloidosis associated with Glu89Gln Mutation. (2019/12/09) ♡
• Transthyretin Anti-Amyloidogenic and Fibril Disrupting Activities of Bacopa monnieri (L.) Wettst (Brahmi) Extract. (2019/12/09) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.